MRÁZ, Marek, Václav ŠEDA, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Jiří MAYER. GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target. In XXVI. CSBMB 2021. 2021.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target
Name (in English) GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target
Authors MRÁZ, Marek, Václav ŠEDA, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Jiří MAYER.
Edition XXVI. CSBMB 2021, 2021.
Other information
Type of outcome Conference abstract
Confidentiality degree is not subject to a state or trade secret
Organization unit Central European Institute of Technology
Changed by Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 18/12/2021 09:43.
Links
MUNI/A/1595/2020, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit VIII (Acronym: VýDiTeHeMa VIII)
Investor: Masaryk University
802644, interní kód MUName: Signaling propensity in the microenvironment of B cell chronic lymphocytic leukemia (Acronym: LeukemiaEnviron)
Investor: European Union, ERC (Excellent Science)
PrintDisplayed: 15/7/2024 21:55